
CPO-IGAN Study: 10-year analysis of treatment in IgAN patients in China
In this medfyle
IgAN is progressive disease that can cause chronic kidney disease and kidney failure. Treatment choices for individual patients remain challenging. This study reveals management practices in China – and how they have changed in response to new data and guidelines.
About this Medfyle
©2024 Infomedica-Medfyle. All rights reserved.
Source: A 10-Year Analysis of IgAN Management in China: Results from the CPO-IGAN Study. Lin FF, et al. Presented at Kidney Week 2024; #FR-PO879.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.